Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

AstraZeneca (AZN)

  • Technical Exchange News
  • Feb. 02, 2026, 08:50 UTC
  • 46
  • 0 comments

NYSE symbol attribute type Security_Name was changed. Previous value: -. New value: AstraZeneca PLC Ordinary Shares.

Comment Full text

AstraZeneca (AZN)

  • Technical Exchange News
  • Feb. 02, 2026, 08:50 UTC
  • 41
  • 0 comments

NYSE symbol attribute type Test_mode was changed. Previous value: -. New value: N.

Comment Full text

AstraZeneca (AZN)

  • Technical Exchange News
  • Feb. 02, 2026, 08:21 UTC
  • 46
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: N. New value: AstraZeneca PLC - American Depositary Shares.

Comment Full text

AstraZeneca (AZN)

  • Technical Exchange News
  • Feb. 02, 2026, 08:21 UTC
  • 43
  • 0 comments

NASDAQ symbol attribute type Test_mode was changed. Previous value: N. New value: AstraZeneca PLC - American Depositary Shares.

Comment Full text

AstraZeneca (AZN)

  • Technical Exchange News
  • Feb. 02, 2026, 08:21 UTC
  • 46
  • 0 comments

NASDAQ symbol attribute type Security_Name was changed. Previous value: AstraZeneca PLC - American Depositary Shares. New value: AstraZeneca PLC - American Depositary Shares.

Comment Full text

AstraZeneca (AZN)

  • Technical Exchange News
  • Feb. 02, 2026, 00:20 UTC
  • 40
  • 0 comments

NYSE traded attribute type Security_Name was changed. Previous value: AstraZeneca PLC - American Depositary Shares. New value: AstraZeneca PLC Ordinary Shares.

Comment Full text

AstraZeneca (AZN)

  • Technical Exchange News
  • Feb. 02, 2026, 00:20 UTC
  • 51
  • 0 comments

NYSE traded attribute type Financial_Status was changed. Previous value: Normal. New value: .

Comment Full text

Aprea Therapeutics Inc. (APRE)

  • Technical Exchange News
  • Jan. 31, 2026, 02:43 UTC
  • 53
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Aprea Therapeutics Inc. (APRE)

  • Technical Exchange News
  • Jan. 30, 2026, 18:49 UTC
  • 57
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Tempest Therapeutics Inc. (TPST)

  • Technical Exchange News
  • Jan. 30, 2026, 03:02 UTC
  • 45
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text
  • Previous
  • 37
  • 38
  • 39
  • 40
  • 41
  • Next

Search

News categories

  • Technical Exchange News(11257)
  • Event(2616)
  • SEC News(198392)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(131562)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin